Re: Effect of dutasteride on the risk of prostate cancer

Re: Effect of dutasteride on the risk of prostate cancer

Библиографические подробности
Главные авторы:	Sooriakumaran, P, Tewari, A
Формат:	Journal article
Язык:	English
Опубликовано:	2010

Схожие документы

Words of wisdom. Re: Effect of dutasteride on the risk of prostate cancer. Andriole GL, Bostwick DG, Brawley OW, et al.
по: Sooriakumaran, P, и др.
Опубликовано: (2010)

Endorectal MRI: Use in Prostate Cancer
по: Srivastava, A, и др.
Опубликовано: (2012)

Predictive models for worsening prognosis in potential candidates for active surveillance of presumed low-risk prostate cancer.
по: Sooriakumaran, P, и др.
Опубликовано: (2012)

Prostate volume and its correlation with histopathological outcomes in prostate cancer.
по: Sooriakumaran, P, и др.
Опубликовано: (2011)

The risks and benefits of cyclo-oxygenase-2 inhibitors in prostate cancer: a review.
по: Sooriakumaran, P, и др.
Опубликовано: (2005)

Management of prostate cancer. Part 1: chemoprevention.
по: Sooriakumaran, P
Опубликовано: (2006)

Smarter screening for prostate cancer: for the few, not the many? A stratified approach based on baseline risk.
по: Sooriakumaran, P
Опубликовано: (2011)

RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
по: Brenna, J, и др.
Опубликовано: (2014)

Does the introduction of prostate multiparametric MRI into active surveillance of localised prostate cancer improve patient re-classification?
по: Bryant, R, и др.
Опубликовано: (2018)

Future prospects: who is the patient who still dies of prostate cancer following local treatment of high-risk prostate cancer? Can we prolong their lives using modern treatment approaches?
по: Ayres, B, и др.
Опубликовано: (2013)

Management of prostate cancer. Part 3: metastatic disease.
по: Shah, J, и др.
Опубликовано: (2006)

Angiogenesis and the tumour hypoxia response in prostate cancer: a review.
по: Sooriakumaran, P, и др.
Опубликовано: (2005)

Gleason scoring varies among pathologists and this affects clinical risk in patients with prostate cancer.
по: Sooriakumaran, P, и др.
Опубликовано: (2005)

Minimally invasive surgical modalities in the management of localized prostate cancer.
по: Jamal, K, и др.
Опубликовано: (2008)

Metformin and prostate cancer: a new role for an old drug
по: Whitburn, J, и др.
Опубликовано: (2017)

Management of prostate cancer. Part 2: localized and locally advanced disease.
по: Sooriakumaran, P, и др.
Опубликовано: (2006)

Clinicopathological strategies to identify contralateral prostate cancer involvement in potential candidates for focal therapy.
по: Grover, S, и др.
Опубликовано: (2010)

Familial risk of prostate cancer in Iceland.
по: Eldon, B, и др.
Опубликовано: (2003)

Management of low-risk prostate cancer.
по: Gardiner, R, и др.
Опубликовано: (2008)

Vasectomy and the Risk of Prostate Cancer COMMENTS
по: Goldacre, M
Опубликовано: (2008)

Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy.
по: Tewari, A, и др.
Опубликовано: (2012)

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group.
по: Vickers, A, и др.
Опубликовано: (2010)

Reply from authors re: Anders Bjartell "a robot saved my life": Is it a myth? Eur Urol 2012;62:775-6: The debate on the oncologic safety of robotics in prostate cancer is over: Time to move on
по: Sooriakumaran, P, и др.
Опубликовано: (2012)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
по: Shui, I, и др.
Опубликовано: (2014)

COX-2 inhibition: a possible role in the management of prostate cancer?
по: Sooriakumaran, P, и др.
Опубликовано: (2007)

Prostate cancer (PCa) risk variants and risk of fatal PCa in the national cancer institute breast and prostate cancer cohort consortium
по: Shui, I, и др.
Опубликовано: (2014)

Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpoint.
по: Sooriakumaran, P, и др.
Опубликовано: (2012)

Epidemiology of metabolite profile and prostate cancer risk
по: Schmidt, J
Опубликовано: (2017)

Radical therapy may reduce mortality in men with metastatic prostate cancer
по: Sooriakumaran, P, и др.
Опубликовано: (2014)

A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.
по: Sooriakumaran, P, и др.
Опубликовано: (2009)

Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.
по: Rohrmann, S, и др.
Опубликовано: (2013)

Smoking and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition
по: Rohrmann, S, и др.
Опубликовано: (2013)

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
по: Chen, Y, и др.
Опубликовано: (2007)

n-3 Fatty acids and prostate cancer risk.
по: Brasky, T, и др.
Опубликовано: (2012)

Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes.
по: Sooriakumaran, P, и др.
Опубликовано: (2014)

Identification of new genetic risk factors for prostate cancer.
по: Guy, M, и др.
Опубликовано: (2009)

Prostate cancer /
по: 375298 Cramer, Scott D.
Опубликовано: (2007)

Cumulative prostate cancer risk assessment with the aid of the free-to-total prostate specific antigen ratio.
по: Aus, G, и др.
Опубликовано: (2004)

Models to predict positive prostate biopsies using the Tyrol screening study.
по: Sooriakumaran, P, и др.
Опубликовано: (2011)

Plasma selenium concentration and prostate cancer risk Reply
по: Allen, N, и др.
Опубликовано: (2009)